Form 4: Director Michael Ellenbogen Executes Stock Option Sale
Statement of Changes in Beneficial Ownership
Evolv Technologies Director Michael Ellenbogen exercised options and sold 80,745 shares of Class A Common Stock.
Summary
- Director Michael Ellenbogen exercised stock options for 80,745 shares at a strike price of $0.24.
- Following the exercise, the director sold the entire block of 80,745 shares at a weighted average price of $6.32 per share.
- The transactions were executed on April 15, 2026, pursuant to a Rule 10b5-1 trading plan established on June 12, 2025.
- Post-transaction, the director retains direct ownership of 2,083,961 shares and indirect ownership of 151,135 shares via the Family Horizon Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted through a pre-established 10b5-1 plan, which is a routine mechanism for insider liquidity.
Positives
- The transaction was pre-planned under a Rule 10b5-1 trading plan, indicating the sale was not based on immediate non-public information.
Negatives
- The transaction represents a divestment of equity by a company director.
Risks
- Continued reliance on Rule 10b5-1 plans for liquidity by insiders may be perceived by some investors as a signal of limited long-term confidence.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives and directors to manage personal liquidity and diversify portfolios, and is generally viewed as neutral by the market when pre-arranged.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate insiders to avoid potential allegations of insider trading.
Stakeholder Impact
- Minimal impact expected as the transaction was pre-planned and represents a small fraction of the director's total holdings.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2018-01-31 | Initial vesting date for the stock options exercised. |
| 2025-06-12 | Date the Rule 10b5-1 trading plan was entered into. |
| 2026-04-15 | Date of the option exercise and subsequent share sale. |
| 2026-04-17 | Date of filing. |
| 2027-09-13 | Expiration date of the stock options. |
Keywords
Evolv Technologies, EVLV, Insider Trading, Form 4, Stock Options, Director Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.